✦ LIBER ✦

Active immunotherapy of stage IV renal cell cancer using autologous tumor cells

✍ Scribed by T. Schärfe; E. Becht; K. F. Klippel; G. H. Jacobi; R. Hohenfellner

Book ID: 104852631
Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 594 KB
Volume: 3
Category: Article
ISSN: 0724-4983
DOI: 10.1007/bf00632186

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal cell carcinoma treated by vaccines

Renal cell carcinoma treated by vaccines for active specific immunotherapy: Correlation of survival with skin testing by autologous tumor cells

✍ Craig S. McCune; Robert W. O'Donnell; Diana M. Marquis; Deepak M. Sahasrabudhe 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 879 KB

Immunotherapy for malignant gliomas: emp

Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells

✍ Steven De Vleeschouwer; Stefaan W. Van Gool; Frank Van Calenbergh 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 478 KB

Active specific immunotherapy with Newca

Active specific immunotherapy with Newcastle-diseasevirus-modified autologous tumor cells following resection of liver metastases in colorectal cancer

✍ Peter Schlag; Maria Manasterski; Thomas Gerneth; Peter Hohenberger; Margret Duec 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 586 KB

Autologous lymph node cell-derived tumor

Autologous lymph node cell-derived tumor-specific cytotoxic t-cells for use in adoptive immunotherapy of human melanoma

✍ Timothy L. Darrow; Craig L. Slingluff; Hilliard F. Seigler 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 820 KB

Phase I study of the adoptive immunother

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

✍ Amitabha Mazumder; Timothy J. Eberlein; Elizabeth A. Grimm; Debra J. Wilson; And 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 977 KB

Immunotherapy of advanced renal cell can

Immunotherapy of advanced renal cell cancer using subcutaneous recombinant interleukin-2 and interferon-α

✍ H. Kirchner; W. Riese; E. Allhoff; H. Poliwoda; J. Atzpodien 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 450 KB

The combined administration of subcutaneous recombinant human interleukin-2 (rIL-2) and interferon-a (rIFN-~) was studied in a phase II trial on patients with advanced progressive renal cell cancer. Safety, tolerance and clinical response rate of this outpatient treatment protocol were assessed in 2